STEPHANIE CATUOGNO: Open Payments
NPI 1255769261 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 205 payments from 21 companies in 2025. Trend: 2023 $2,605 · 2024 $1,905 · 2025 $3,441
Food & beverage: $3,142Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $391 |
| Arcutis Biotherapeutics, Inc. | 14 | $343 |
| Novartis Pharmaceuticals Corporation | 17 | $289 |
| Paratek Pharmaceuticals, Inc. | 25 | $270 |
| UCB, Inc. | 12 | $270 |
| GENZYME CORPORATION | 11 | $270 |
| PFIZER INC. | 14 | $249 |
| ABBVIE INC. | 19 | $208 |
| Galderma Laboratories, L.P. | 20 | $205 |
| E.R. Squibb & Sons, L.L.C. | 9 | $174 |
Products named: DUPIXENT, TREMFYA, Zoryve, NUZYRA, Bimzelx, CIBINQO, COSENTYX, Sotyktu.
Industry payments across TX — which companies pay providers there.
